NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
NurExone Biologic's U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization
NurExone Biologic's U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization
NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
NurExone Biologic Advances Manufacturing and Regulatory Roadmap with Independent Batch Consistency Results for Exosome Production
NurExone Appoints Eyal Gabbai to Board, Adding Large-Scale Healthcare System and Capital Markets Expertise
NurExone Plans Small-Scale of ExoPTEN Clinical Manufacturing in Preparation for FUTURE First in Human USE Pathways
NurExone Accepted into ARMI's BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing
Juggernaut Mobilizes For Inaugural 10,000 Meter Drill Program to Test New District Scale High Grade Gold Silver Copper Rich Discovery at 100% Controlled Big One Property, Golden Triangle, B.C
Prince Reports 27.43 Metres Grading 93.7 g/t Silver, 12.0% Mn, 2.29% Pb and 2.48% Zn at Its Prince Silver Project in Nevada;
Market One: Standard Uranium Ltd. Prepares to Drill Its Flagship Davidson River Uranium Project in Saskatchewan's Athabasca Basin
